Physician profile
Lawrence R Dultz
NPI 1255448916
$2,106.43
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,825 · 2020: $69.75 · 2021: $212.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $474.84 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.02 | 2019 | |
| Fisher & Paykel Healthcare INC | $230.32 | 2019 | |
| Sunovion Pharmaceuticals INC. | $202.98 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $186.89 | 2019-2021 | |
| United Therapeutics Corporation | $160.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $142.84 | 2019 | |
| Novartis Pharmaceuticals Corporation | $73.06 | 2019 | |
| Philips North America LLC | $51.57 | 2019 | |
| Shire North American Group INC | $45.74 | 2019 | |
| Mylan Specialty L.P. | $39.18 | 2019 | |
| Advanced Respiratory, INC | $37.17 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.58 | 2019 | |
| Insmed, INC. | $27.66 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $26.13 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $23.61 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $23.12 | 2019 | |
| Pulmonx Corporation | $17.67 | 2020 | |
| Veran Medical Technologies, INC. | $15.64 | 2019 | |
| Grifols USA, LLC | $15.00 | 2019 | |
| Electromed, INC. | $12.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Dultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.